Use of a meal replacement weight loss intervention in survivors of ER/PR-negative breast cancer

被引:0
|
作者
Milliron, B.
Hopkins, J. O.
Fulmer, A.
Case, L. D.
Vitolins, M.
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[2] Forsyth Reg Canc Ctr, Winston Salem, NC USA
关键词
D O I
10.1200/jco.2011.29.27_suppl.166
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
166
引用
收藏
页数:1
相关论文
共 50 条
  • [11] A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women
    Lee, Ji Shin
    Lai, Pang-Kuo
    Fackler, Mary Jo
    Argani, Pedram
    Zhang, Zhe
    Garrett-Mayer, Elizabeth
    Sukumar, Saraswati
    CANCER BIOLOGY & THERAPY, 2007, 6 (07) : 1114 - 1120
  • [12] Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype
    Kuo-Wang Tsai
    Guan-Cheng Li
    Chien-Hsun Chen
    Ming-Hsin Yeh
    Jer-Shyung Huang
    Hui-Hwa Tseng
    Ting-Ying Fu
    Huei-Han Liou
    Hung-Wei Pan
    Sheng-Feng Huang
    Chien-Chou Chen
    Hui-Yu Chang
    Luo-Ping Ger
    Hong-Tai Chang
    Breast Cancer Research and Treatment, 2015, 153 : 219 - 234
  • [13] Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers
    Donata Micello
    Alessandro Marando
    Nora Sahnane
    Cristina Riva
    Carlo Capella
    Fausto Sessa
    Virchows Archiv, 2010, 457 : 467 - 476
  • [14] Breast cancer survivors’ perspectives on a weight loss and physical activity lifestyle intervention
    Lynda G. Balneaves
    Cheri Van Patten
    Tracy L. O. Truant
    Mary T. Kelly
    Sarah E. Neil
    Kristin L. Campbell
    Supportive Care in Cancer, 2014, 22 : 2057 - 2065
  • [15] Breast cancer survivors' perspectives on a weight loss and physical activity lifestyle intervention
    Balneaves, Lynda G.
    Van Patten, Cheri
    Truant, Tracy L. O.
    Kelly, Mary T.
    Neil, Sarah E.
    Campbell, Kristin L.
    SUPPORTIVE CARE IN CANCER, 2014, 22 (08) : 2057 - 2065
  • [16] Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype
    Tsai, Kuo-Wang
    Li, Guan-Cheng
    Chen, Chien-Hsun
    Yeh, Ming-Hsin
    Huang, Jer-Shyung
    Tseng, Hui-Hwa
    Fu, Ting-Ying
    Liou, Huei-Han
    Pan, Hung-Wei
    Huang, Sheng-Feng
    Chen, Chien-Chou
    Chang, Hui-Yu
    Ger, Luo-Ping
    Chang, Hong-Tai
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 219 - 234
  • [17] Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers
    Micello, Donata
    Marando, Alessandro
    Sahnane, Nora
    Riva, Cristina
    Capella, Carlo
    Sessa, Fausto
    VIRCHOWS ARCHIV, 2010, 457 (04) : 467 - 476
  • [18] A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape
    Peiling Xie
    Rui An
    Shibo Yu
    Jianjun He
    Huimin Zhang
    Journal of Translational Medicine, 19
  • [19] A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape
    Xie, Peiling
    An, Rui
    Yu, Shibo
    He, Jianjun
    Zhang, Huimin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [20] Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
    Taobo Hu
    Yan Chen
    Yiqiang Liu
    Danhua Zhang
    Jiankang Pan
    Mengping Long
    BMC Medical Research Methodology, 21